Amphastar Pharmaceuticals, Inc. (AMPH)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$21.88
+1.06%
Mkt Cap $953.23M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 26, 2026 | $188.77M | $183.10M | -3.00% | $0.90 | $0.73 | -19.16% | — | — |
| Q4 2025 Nov 6, 2025 | $190.48M | $191.84M | +0.71% | $0.77 | $0.93 | +20.78% | — | — |
| Q3 2025 Aug 7, 2025 | $177.10M | $174.41M | -1.52% | $0.71 | $0.85 | +19.72% | — | — |
| Q2 2025 May 7, 2025 | $173.06M | $170.53M | -1.46% | $0.66 | $0.74 | +12.12% | — | — |
| Q1 2025 Feb 27, 2025 | $188.78M | $186.52M | -1.19% | $1.01 | $0.92 | -8.91% | — | — |
| Q4 2024 Nov 6, 2024 | $192.08M | $188.82M | -1.70% | $0.99 | $0.96 | -3.03% | — | — |
| Q3 2024 Aug 7, 2024 | $170.94M | $182.39M | +6.70% | $0.77 | $0.94 | +22.08% | — | — |
| Q2 2024 May 8, 2024 | $174.71M | $171.84M | -1.65% | $0.96 | $1.04 | +8.33% | — | — |
| Q1 2024 Feb 28, 2024 | $175.67M | $178.10M | +1.39% | $0.93 | $0.88 | -5.38% | — | — |
| Q4 2023 Nov 8, 2023 | $176.63M | $180.56M | +2.22% | $0.69 | $1.15 | +66.67% | — | — |
| Q3 2023 Aug 8, 2023 | $137.37M | $145.71M | +6.07% | $0.56 | $0.65 | +16.07% | — | — |
| Q2 2023 May 9, 2023 | $136.33M | $140.02M | +2.71% | $0.48 | $0.62 | +29.17% | — | — |
| Q1 2023 Feb 28, 2023 | $127.18M | $135.02M | +6.16% | $0.41 | $0.73 | +78.05% | — | — |
| Q4 2022 Nov 7, 2022 | $125.98M | $120.13M | -4.64% | $0.39 | $0.38 | -2.56% | — | — |
| Q3 2022 Aug 8, 2022 | $118.08M | $123.47M | +4.56% | $0.35 | $0.39 | +11.43% | — | — |
| Q2 2022 May 9, 2022 | $113.33M | $120.37M | +6.21% | $0.36 | $0.47 | +30.56% | — | — |
| Q1 2022 Mar 10, 2022 | $111.62M | $120.89M | +8.30% | $0.36 | $0.42 | +16.67% | — | — |
| Q4 2021 Nov 8, 2021 | $78.10M | $112.20M | +43.66% | $0.24 | $0.46 | +91.67% | — | — |
| Q3 2021 Aug 9, 2021 | $101.38M | $101.66M | +0.28% | $0.21 | $0.21 | +0.00% | — | — |
| Q2 2021 May 6, 2021 | $84.99M | $103.02M | +21.21% | $0.19 | $0.27 | +42.11% | — | — |